Vaccine boosters from Pfizer/BioNTech were approved by the FDA for people aged 65 or older and other groups ''at high risk of severe COVID-19.'
) has authorized Pfizer/BioNTech COVID-19 booster shots for"certain populations" who are at risk of developing severe disease.
On Wednesday, the FDA approved limited boosters for the Pfizer/BioNTech vaccines at least six months after recipients aged 65 and over received their second dose. The agency said that some younger individuals who received the vaccine would also qualify, although specific eligibility details were unclear. Booster shots have not yet been approved for recipients of the Moderna and Johnson & Johnson vaccines.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA authorizes Pfizer-BioNTech booster shot for elderly, people at high risk of severe Covid-19Pfizer-BioNTech booster shots are now authorized by the FDA for people 65 and older and for certain high-risk adult populations
Read more »
FDA Authorizes Pfizer COVID Vaccine Booster Shots For Americans 65 And OlderPfizer said a third shot would restore the effectiveness of its COVID-19 vaccine to about 95%.
Read more »
FDA authorizes booster dose of Pfizer's Covid-19 vaccine for people 65 and olderThe FDA granted emergency use authorization for a booster dose of Pfizer's Covid-19 vaccine in people 65 and older, people at high risk of severe disease and people whose jobs put them at risk of infection.
Read more »
J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decisionJohnson & Johnson became the latest COVID-19 vaccine maker to offer an update on booster doses Tuesday, when it said data from a Phase 3 trial and the real...
Read more »
The FDA could authorize Covid-19 vaccines for young children in weeks, expert saysThe US Food and Drug Administration could soon authorize a Pfizer/BioNTech Covid-19 vaccine for young children, experts said
Read more »